Phase
Condition
Asthma
Cystic Fibrosis
Lung Disease
Treatment
Lung Clearance Index
Xenon-129 and Perfluoropropane (19F)
Magnetic Resonance Imaging
Clinical Study ID
Ages > 8 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants male and female aged 8 years old and older.
Participants have no smoking history.
For participants with CF and asthma, a clinical diagnosis is necessary and theyshould be at their baseline level of symptom control based on history.
Participants should have a FEV1%pred value greater than 40%.
Participant understands the study procedures and is willing to participate in thestudy as indicated by signature on the informed consent or assent.
Participant must be able to perform a breath hold for 20s or less.
Participant able to perform reproducible pulmonary function tests (i.e., the 3 bestacceptable spirograms have FEV1 values that do not vary more than 5% of the largestvalue or more than 100 ml, whichever is greater).
For the PEx sub-cohort, admission to the Hospital for Sick Children for a pulmonary exacerbation (based on clinical or pulmonary function assessment). Children who will be admitted and then discharged on home IV antibiotics may also be included in this study.
Exclusion
Exclusion Criteria:
Participant is, in the opinion of the investigator, mentally or legallyincapacitated, preventing informed consent/assent from being obtained, or cannotread or understand the written material.
Participant has a history of cardiovascular disorders including coronaryinsufficiency, cardiac arrhythmias, severe hypertension.
Other than for the PEx sub-cohort, participant has had a cold or respiratoryinfection in the last four weeks.
Participant requires supplemental oxygen or has a daytime room air oxygen saturation ≤ 95%.
Participant is unable to perform spirometry or plethysmography maneuvers.
Participant is pregnant or lactating.
In the investigator's opinion, participant suffers from any physical, psychologicalor other condition(s) that might prevent performance of the MRI, such as severeclaustrophobia.
Participant has an MRI incompatible device or any metal in their body which cannotbe removed, including but not limited to pacemakers, neurostimulators,biostimulators, implanted insulin pumps, aneurysm clips, bio prosthetic, artificiallimb, metallic fragment or foreign body, shunt, surgical staples (including clips ormetallic sutures and/or ear implants).
Study Design
Study Description
Connect with a study center
The Hospital for Sick Children
Toronto, Ontario M5G 1X8
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.